Inveon small animal pet scanner
The Inveon small-animal PET scanner is a laboratory equipment designed for high-resolution imaging of small animals. It is capable of producing detailed images of the internal structures and functions of small animals, such as mice and rats, using positron emission tomography (PET) technology. The core function of the Inveon PET scanner is to enable non-invasive, in vivo imaging of small-animal subjects for research purposes.
Lab products found in correlation
26 protocols using inveon small animal pet scanner
Multimodal Molecular Imaging Protocol
PET Imaging of Tumor and Infection
Tumor-Targeted Zirconium-89 Imaging
FDG-PET Imaging in Mice
PET Imaging of Panc02 Tumors with Ga-FAPI-RGD
In vivo PET Imaging of Radiolabeled Compounds
Radiolabelled Nanoparticle Biodistribution
In Vivo PET Imaging of Tumor Uptake of 64Cu-Doped Gold Nanoparticles
Multimodal Imaging of SCNPs in Tumor
SCNPs were labelled with radioactive copper (64Cu) by mixing 64CuCl2 with SCNPs@DOTA at 37 °C for 1 h under constant stirring. As detected by thin-layer chromatography, the radiolabeling yield of SCNPs@DOTA was determined to be as high as 98%. For PET imaging, 64Cu SCNPs@DOTA (150 μCi, 100 μL) was intravenously injected into the HeLa tumour-bearing mice. The mice were anaesthetised with isoflurane (1.0 ~ 2.0%) in oxygen delivered at a flow rate of 1.0 L min−1. All PET imagings were carried out on Inveon small-animal PET scanner (Siemens, Erlangen, Germany) at different times post-injection. For each in vivo PET scan, 3D volumes of interest were drawn over the tumour and muscle on decay-corrected whole-body coronal images, which were analysed by Inveon Research Workplace. Standards were prepared and the tumour uptake was determined as percent of injected dose per gram of tissue.
Comparative Analysis of 68Ga-DOTA-2P(FAPI)2 and 68Ga-FAPI-46 in HCC-PDX Models
In the biodistribution study, the products of 68Ga-DOTA-2P(FAPI)2 and 68Ga-FAPI-46 were diluted to a concentration of 14.8 MBq/mL. HCC-PDX mice were injected with the same batch of 1.48-MBq 68Ga-DOTA-2P(FAPI)2 and killed at different times (1 and 4 h after injection; n = 3 for each time point). The main organs and tumors were isolated, weighed, and analyzed. The biodistribution in the 68Ga-FAPI-46 group (1.48 MBq) and the blocking group (68Ga-DOTA-2P(FAPI)2 [1.48 MBq] with 30 nmol of unlabeled FAPI-46) was also evaluated for comparison. The radioactivity (counts per minute) was measured with a γ-counter.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!